BioSpace News Archive

Eliminated Need for Prophylaxis and No Spontaneous Bleeds in Year 2 Quality of Life Scores Continue to Increase in Year 2

Next-generation Suspension Formulation Designed to Improve Tolerability and Treatment Response in Patients with Wet AMD IND Amendment in US and CTAs Filed in EU for Phase 1/2 Trial

New Walgreens survey aims to raise childhood poverty awareness in advance of Red Nose Day in the U.S., May 24

OptiScan Biomedical Corporation, a developer of an innovative continuous monitoring system for use in the surgical intensive care unit (SICU), today announced that Cary G. Vance has been appointed president and chief executive officer (CEO), as well as a member of the company’s board of directors. Mr. Vance is replacing William Mince, who has served as OptiScan’s interim CEO since October 2017.

WCG expands global clinical research support presence

Broad Action Against Multidrug Resistant Pathogens Leads to Name Change from Novoclem Therapeutics to Vast Therapeutics.

RSV affects 33 million children globally and leads to approximately 120,000 childhood deaths every year1 In the United States approximately 177,000 older adults are hospitalized annually because of RSV2

Keynote at Drug Discovery Innovation Programme and Company Presentation at JMP Securities Life Sciences Conference

New investment fuels continued innovation, market expansion, and necessary developments for more complex, higher-value care

Visionary Ventures Fund, L.P. and Bluestem Capital Lead the Funding, Providing Growth Capital for the iLux® Evaporative Dry Eye System